Xencor (XNCR) Net Margin (2013 - 2026)

Xencor (XNCR) reported Net Margin of 2854.65% for Q1 2026, down 270597.0% year-over-year from N/an in Q1 2025, and down 11984.97% quarter-over-quarter from 23.62% in Q4 2025.

Xencor (XNCR) Net Margin (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Net Margin data on file, last reported at 2854.65% in Q1 2026.

  • Net Margin for Q1 2026 came in at 2854.65%, down 270597.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 177.06% (down 1115.0% YoY), and the FY2025 annual result was 73.37%, up 14071.0% from the prior year.
  • Net Margin retreated to 2854.65% in Q1 2026 per XNCR's latest filing, from 23.62% in the prior quarter.
  • Over five years, Net Margin peaked at 27.6% in Q1 2022 and troughed at 2854.65% in Q1 2026.
  • A 5-year average of 290.99% and a median of 87.51% in 2024 frame the typical range for Net Margin.
  • The sharpest annual moves came in 2025 and 2026: Net Margin surged 31463 bps in 2025, then slumped 270597 bps in 2026.
  • A 5-year view of Net Margin shows it stood at 55.75% in 2022, then rose by 7 bps to 51.57% in 2023, then sank by 70 bps to 87.51% in 2024, then jumped by 73 bps to 23.62% in 2025, then slumped by 11985 bps to 2854.65% in 2026.
  • Business Quant data shows XNCR's Net Margin at 2854.65% in Q1 2026, 23.62% in Q4 2025, and 28.7% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Xencor 953.38 Mn 878.64 Mn - -2,854.65%

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,854.65%
Dec 31, 2025 -23.62%
Sep 30, 2025 -28.70%
Jun 30, 2025 -70.57%
Mar 31, 2025 -148.68%
Dec 31, 2024 -87.51%
Sep 30, 2024 -266.59%
Jun 30, 2024 -287.71%
Mar 31, 2024 -463.31%
Dec 31, 2023 -51.57%
Sep 30, 2023 -41.02%
Jun 30, 2023 -57.12%
Mar 31, 2023 -305.09%
Dec 31, 2022 -55.75%
Sep 30, 2022 -120.00%
Jun 30, 2022 -112.50%
Mar 31, 2022 27.60%
Dec 31, 2021 47.44%
Sep 30, 2021 -204.19%
Jun 30, 2021 77.47%